SHARE

CapVest to acquire majority stake in German drugmaker Stada, valuing firm at €10bn 

London-based buyout group CapVest will acquire around 70% of Stada, ending the German firm’s IPO plans. Sellers Bain and Cinven, which bought Stada in 2017, will each retain a minority holding. Deal closing is expected in early 2026.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.